Short Review: SARS-CoV-2 Vaccines
SARS-CoV-2 Vaccines – JAMA Author interview: Coronavirus Vaccines—An Overview Check out the Table ins this #SARSCoV2 Vaccine Overview – everything you wanted to know about upcoming vaccines – Oxford/AZ, Sputnik, Sinovac, more! https://t.co/TWbgfSKBIP — JAMA (@JAMA_current) February 26, 2021
The post Short Review: SARS-CoV-2 Vaccines appeared first on Links Medicus.
CDC Study: Suspected SARS-CoV-2 reinfections in a skilled nursing facility
Suspected Recurrent SARS-CoV-2 Infections Among Residents of a Skilled Nursing Facility During a Second COVID-19 Outbreak — Kentucky, July–November 2020 – CDC Morbidity and Mortality Weekly Report Commentaries: Possible SARS-CoV-2 Reinfection Described at Skilled Nursing Facility – HealthDay AND Reinfections could be more likely among those with a mild first case of COVID-19: case study […]
The post CDC Study: Suspected SARS-CoV-2 reinfections in a skilled nursing facility appeared first on Links Medicus.
WHO Report: Preparing for Long COVID 2021
In the wake of the pandemic: preparing for Long COVID (2021) – World Health Organization News release: New policy brief calls on decision-makers to support patients as 1 in 10 report symptoms of “long COVID” – World Health Organization Commentaries: Long COVID sufferer still has disease’s debilitating symptoms nearly a year after first falling ill […]
The post WHO Report: Preparing for Long COVID 2021 appeared first on Links Medicus.
Perspective: Coronavirus reinfection will soon become our reality
Coronavirus reinfection will soon become our reality – The Atlantic (a few articles per month are free)
The post Perspective: Coronavirus reinfection will soon become our reality appeared first on Links Medicus.
People with SARS-CoV-2 antibodies may have a low risk of future infection
Association of SARS-CoV-2 Seropositive Antibody Test With Risk of Future Infection – JAMA Internal Medicine Editorial: How to Advise Persons Who Are Antibody Positive for SARS-CoV-2 About Future Infection Risk Commentaries: Covid-19 antibodies may protect against reinfection later, study suggests – CNN AND NCI study finds that people with SARS-CoV-2 antibodies may have a low […]
The post People with SARS-CoV-2 antibodies may have a low risk of future infection appeared first on Links Medicus.
ASCO Guideline: Management of dyspnea in advanced cancer
Management of Dyspnea in Advanced Cancer: ASCO Guideline – Journal of Clinical Oncology Commentary on Twitter (thread – click for more) 1/ How can we better manage dyspnea in people with advanced cancer? Wonderful to see this new @ASCO Guideline out. Led by Drs. @DrDavidHui and @campbell_meg #supponc #pallonc Full text: https://t.co/qbdhzbibKw pic.twitter.com/f2Qf6GswvK — […]
The post ASCO Guideline: Management of dyspnea in advanced cancer appeared first on Links Medicus.
Study: Patients with severe COVID-19 might shed viable virus during prolonged periods of up to 4 weeks
Prolonged SARS-CoV-2 cell culture replication in respiratory samples from patients with severe COVID-19 – Clinical Microbiology and Infection Commentary on Twitter Different pattern of SARS-CoV-2 viability in mild cases (viral replication max 10 days) vs severe COVID-19: viable virus demonstrated up to 4 weeks even in the presence of high levels of neutralizing activityhttps://t.co/dhERkipKJ0 […]
The post Study: Patients with severe COVID-19 might shed viable virus during prolonged periods of up to 4 weeks appeared first on Links Medicus.
M-A: Asthma does not increase the risk of infection, hospitalization, ICU admission, and mortality from COVID-19
Asthma and risk of infection, hospitalisation, ICU admission and mortality from COVID-19: Systematic review and meta-analysis – Journal of Asthma Commentary: Study: Asthma does not increase risk of severe illness or death from COVID-19 – News Medical See also: COVID vaccine and asthma: why most sufferers won’t be prioritised in the next phase of rollout – […]
The post M-A: Asthma does not increase the risk of infection, hospitalization, ICU admission, and mortality from COVID-19 appeared first on Links Medicus.
Editorial: Prophylactic anticoagulation for patients in hospital with covid-19
Prophylactic anticoagulation for patients in hospital with covid-19 – The BMJ Related: Full-dose Heparin best for moderate COVID-19 regardless of D-dimer — Data released from ACTIV-4a, ATTACC, and REMAP-CAP trials AND Cohort study: Early initiation of prophylactic anticoagulation linked to reduced mortality in patients admitted to hospital with Covid-19
The post Editorial: Prophylactic anticoagulation for patients in hospital with covid-19 appeared first on Links Medicus.
FDA issues alert on ‘limitations’ of pulse oximeters, without explicit mention of racial bias
FDA issues alert on ‘limitations’ of pulse oximeters, without explicit mention of racial bias – STAT FDA Safety Alert: Pulse Oximeter Accuracy and Limitations: FDA Safety Communication – U.S. Food & Drug Administration Related: “Racial Bias in Pulse Oximetry Measurement”. In two large cohorts, Black patients had nearly three times the frequency of occult hypoxemia […]
The post FDA issues alert on ‘limitations’ of pulse oximeters, without explicit mention of racial bias appeared first on Links Medicus.